Application of an Integrated Supply Chain Strategy in the Biopharmaceutical Industry

The paper discusses the unique planning challenges in the biopharmaceutical industry, a highly regulated industry in which time-to-market takes precedence over operational excellence and sponsor organizations rely heavily on virtual supply chain (CMO/CRO) to deliver clinical and commercial products. Effective collaboration among suppliers, contract manufacturers, and downstream customers are critical to efficient operations and commercial launch. Through case studies, the article introduces an integrated supply chain strategy that tightly aligns with corporate objectives. By careful design and implementation of supply chain network, supply chain planning, strategic relationships, and supporting infrastructure, a company can turn a supply chain into a strategic weapon and ensure a successful launch and commercialization of its drug development programs. Failure to do so can lead to product delay and revenue loss.